Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
HCA Stock Summary
Top 10 Correlated ETFs
HCA
In the News
Why HCA Healthcare (HCA) is a Top Value Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
HCA Healthcare (HCA) Exceeds Market Returns: Some Facts to Consider
HCA Healthcare (HCA) concluded the recent trading session at $331.69, signifying a +1.21% move from its prior day's close.
These are the best-performing ‘Big Short” Michael Burry stocks of 2024
While Michael Burry undoubtedly pulled off one of the most masterful stock market maneuvers during the 2008 crisis with his ‘Big Short,' Burry's performance since has been checkered, albeit leaning toward successful.
HCA Healthcare, Inc. 1st Quarter 2024 Earnings Conference Call
NASHVILLE, Tenn.--(BUSINESS WIRE)--HCA Healthcare, Inc. (NYSE: HCA) announces the following Webcast: What: HCA Healthcare, Inc. 1Q Earnings Release Call When: Friday, April 26, 2024 at 9:00 am central (10:00 am eastern) How: Live Audio over the Internet: https://investor.hcahealthcare.com/events-and-presentations/default.aspx Contact: Frank Morgan, 615-344-2688, Vice President, Investor Relations, frank.morgan@hcahealthcare.com If you are unable to listen during the live webcast, the call will.
Investors Heavily Search HCA Healthcare, Inc. (HCA): Here is What You Need to Know
Recently, Zacks.com users have been paying close attention to HCA (HCA). This makes it worthwhile to examine what the stock has in store.
Should Value Investors Buy HCA Healthcare (HCA) Stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
HCA Healthcare (HCA) Stock Slides as Market Rises: Facts to Know Before You Trade
HCA Healthcare (HCA) reachead $328.86 at the closing of the latest trading day, reflecting a -0.49% change compared to its last close.
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
This ‘Big Short' Michael Burry stock is up 50% in a week
The latest filing detailing the stock holdings of the famous investor who predicted the 2008 crash – Michael Burry of “The Big Short” fame – published in mid-February covering the final trimester of 2023 was filled with interesting updates and revelations.
Earnings Growth & Price Strength Make HCA Healthcare (HCA) a Stock to Watch
Finding strong, market-beating stocks with a positive earnings outlook becomes easier with the Focus List, a top feature of the Zacks Premium portfolio service.
HCA Financial details
HCA Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-12-31
Metric | History | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 151.68 | 151.82 | 181.72 | 207.45 | 238.5 | |
Net income per share | 10.36 | 11.06 | 21.51 | 19.44 | 19.24 | |
Operating cash flow per share | 22.46 | 27.2 | 27.71 | 29.35 | 34.62 | |
Free cash flow per share | 10.18 | 18.85 | 16.65 | 14.21 | 17.21 | |
Cash per share | 2.27 | 5.62 | 4.81 | 4.44 | 3.75 | |
Book value per share | -8.3 | 1.69 | -2.89 | -9.53 | -6.51 | |
Tangible book value per share | -26.1 | -16.75 | -24.9 | -33.5 | -32.62 | |
Share holders equity per share | -8.3 | 1.69 | -2.89 | -9.53 | -6.51 | |
Interest debt per share | 109.46 | 100.94 | 117.22 | 143.2 | 151.81 | |
Market cap | 50.03B | 55.82B | 83.07B | 69.67B | 73.73B | |
Enterprise value | 84.63B | 86.71B | 117.95B | 108.6B | 114.66B | |
P/E ratio | 14.27 | 14.87 | 11.94 | 12.35 | 14.07 | |
Price to sales ratio | 0.97 | 1.08 | 1.41 | 1.16 | 1.13 | |
POCF ratio | 6.58 | 6.05 | 9.27 | 8.18 | 7.82 | |
PFCF ratio | 14.53 | 8.73 | 15.43 | 16.88 | 15.73 | |
P/B Ratio | -17.82 | 97.59 | -89.03 | -25.18 | -41.56 | |
PTB ratio | -17.82 | 97.59 | -89.03 | -25.18 | -41.56 | |
EV to sales | 1.65 | 1.68 | 2.01 | 1.8 | 1.76 | |
Enterprise value over EBITDA | 8.59 | 8.64 | 9.33 | 9 | 9.01 | |
EV to operating cash flow | 11.13 | 9.39 | 13.17 | 12.74 | 12.16 | |
EV to free cash flow | 24.57 | 13.55 | 21.92 | 26.31 | 24.46 | |
Earnings yield | 0.07 | 0.07 | 0.08 | 0.08 | 0.07 | |
Free cash flow yield | 0.07 | 0.11 | 0.06 | 0.06 | 0.06 | |
Debt to equity | -12.54 | 57.13 | -38.94 | -14.4 | -22.22 | |
Debt to assets | 0.78 | 0.69 | 0.72 | 0.76 | 0.7 | |
Net debt to EBITDA | 3.51 | 3.08 | 2.76 | 3.23 | 3.22 | |
Current ratio | 1.44 | 1.42 | 1.41 | 1.38 | 1.18 | |
Interest coverage | 3.98 | 4.62 | 6.25 | 5.23 | 4.97 | |
Income quality | 1.83 | 2.1 | 1.16 | 1.25 | 1.8 | |
Dividend Yield | 0.01 | 0 | 0.01 | 0.01 | 0.01 | |
Payout ratio | 0.16 | 0.04 | 0.09 | 0.12 | 0.13 | |
Sales general and administrative to revenue | 0.46 | 0.46 | 0.46 | 0.46 | 0.45 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.18 | 0.18 | 0.19 | 0.18 | 0.18 | |
Capex to operating cash flow | -0.55 | -0.31 | -0.4 | -0.52 | -0.5 | |
Capex to revenue | -0.08 | -0.06 | -0.06 | -0.07 | -0.07 | |
Capex to depreciation | -1.6 | -1.04 | -1.25 | -1.48 | -1.54 | |
Stock based compensation to revenue | 0.01 | 0.01 | 0.01 | 0.01 | 0 | |
Graham number | 43.97 | 20.48 | 37.38 | 64.56 | 53.1 | |
ROIC | 0.17 | 0.17 | 0.21 | 0.19 | 0.19 | |
Return on tangible assets | 0.1 | 0.1 | 0.17 | 0.13 | 0.11 | |
Graham Net | -113.45 | -107.21 | -125.68 | -149.89 | -167.56 | |
Working capital | 3.44B | 3.63B | 3.96B | 3.74B | 2.27B | |
Tangible asset value | -8.83B | -5.69B | -8.05B | -9.73B | -8.89B | |
Net current asset value | -34.43B | -32.27B | -35.71B | -38.87B | -40.22B | |
Invested capital | -12.54 | 57.13 | -38.94 | -14.4 | -22.22 | |
Average receivables | 7.08B | 7.22B | 7.57B | 8.49B | 9.43B | |
Average payables | 2.74B | 3.22B | 3.82B | 4.18B | 4.24B | |
Average inventory | 1.79B | 1.94B | 2.01B | 2.03B | 2.04B | |
Days sales outstanding | 52.47 | 49.94 | 50.29 | 53.88 | 55.99 | |
Days payables outstanding | 125.02 | 154.17 | 158.27 | 165.11 | 156.03 | |
Days of inventory on hand | 79.58 | 88.32 | 76.46 | 80.55 | 74.5 | |
Receivables turnover | 6.96 | 7.31 | 7.26 | 6.77 | 6.52 | |
Payables turnover | 2.92 | 2.37 | 2.31 | 2.21 | 2.34 | |
Inventory turnover | 4.59 | 4.13 | 4.77 | 4.53 | 4.9 | |
ROE | -1.25 | 6.56 | -7.46 | -2.04 | -2.95 | |
Capex per share | -12.29 | -8.35 | -11.06 | -15.14 | -17.42 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q4
Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 55.87 | 56.3 | 57.78 | 59.79 | 65.16 | |
Net income per share | 7.5 | 4.92 | 4.35 | 3.98 | 6.05 | |
Operating cash flow per share | 9.11 | 6.51 | 9.02 | 9.14 | 10.07 | |
Free cash flow per share | 4.34 | 2.19 | 4.5 | 4.91 | 5.71 | |
Cash per share | 4.65 | 4.45 | 3.5 | 3.67 | 3.85 | |
Book value per share | -9.98 | -9.01 | -8.39 | -9.13 | -6.68 | |
Tangible book value per share | -35.06 | -33.79 | -33.44 | -34.74 | -33.46 | |
Share holders equity per share | -9.98 | -9.01 | -8.39 | -9.13 | -6.68 | |
Interest debt per share | 145.25 | 148.25 | 150.18 | 153.43 | 150.28 | |
Market cap | 66.56B | 73.02B | 83.3B | 66.7B | 71.88B | |
Enterprise value | 105.49B | 112.75B | 123.18B | 106.93B | 112.8B | |
P/E ratio | 8 | 13.39 | 17.46 | 15.45 | 11.18 | |
Price to sales ratio | 4.3 | 4.68 | 5.25 | 4.11 | 4.15 | |
POCF ratio | 26.34 | 40.5 | 33.66 | 26.91 | 26.88 | |
PFCF ratio | 55.28 | 120.49 | 67.51 | 50.08 | 47.44 | |
P/B Ratio | -24.05 | -29.26 | -36.17 | -26.93 | -40.52 | |
PTB ratio | -24.05 | -29.26 | -36.17 | -26.93 | -40.52 | |
EV to sales | 6.81 | 7.23 | 7.77 | 6.6 | 6.52 | |
Enterprise value over EBITDA | 33.18 | 35.54 | 40.31 | 37.13 | 31.18 | |
EV to operating cash flow | 41.74 | 62.53 | 49.77 | 43.14 | 42.18 | |
EV to free cash flow | 87.61 | 186.05 | 99.82 | 80.28 | 74.46 | |
Earnings yield | 0.03 | 0.02 | 0.01 | 0.02 | 0.02 | |
Free cash flow yield | 0.02 | 0.01 | 0.01 | 0.02 | 0.02 | |
Debt to equity | -14.4 | -16.26 | -17.69 | -16.6 | -22.22 | |
Debt to assets | 0.76 | 0.77 | 0.76 | 0.75 | 0.7 | |
Net debt to EBITDA | 12.25 | 12.53 | 13.05 | 13.97 | 11.31 | |
Current ratio | 1.38 | 1.23 | 1.2 | 1.15 | 1.18 | |
Interest coverage | 5.36 | 5.04 | 4.73 | 4.37 | 5.7 | |
Income quality | 0.96 | 1.17 | 1.75 | 1.94 | 1.66 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0.07 | 0.13 | 0.14 | 0.15 | 0.1 | |
Sales general and administrative to revenue | 0.46 | 0.45 | 0.46 | 0.47 | 0.44 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.18 | 0.18 | 0.18 | 0.18 | 0.18 | |
Capex to operating cash flow | -0.52 | -0.66 | -0.5 | -0.46 | -0.43 | |
Capex to revenue | -0.09 | -0.08 | -0.08 | -0.07 | -0.07 | |
Capex to depreciation | -1.76 | -1.58 | -1.63 | -1.49 | -1.47 | |
Stock based compensation to revenue | 0.01 | 0 | 0 | 0 | 0 | |
Graham number | 41.04 | 31.59 | 28.64 | 28.6 | 30.16 | |
ROIC | 0.05 | 0.05 | 0.04 | 0.04 | 0.06 | |
Return on tangible assets | 0.05 | 0.03 | 0.03 | 0.02 | 0.03 | |
Graham Net | -156.9 | -157.86 | -162.53 | -167.19 | -171.89 | |
Working capital | 3.74B | 2.51B | 2.34B | 1.89B | 2.27B | |
Tangible asset value | -9.73B | -9.36B | -9.18B | -9.42B | -8.89B | |
Net current asset value | -38.87B | -38.94B | -39.25B | -39.94B | -40.22B | |
Invested capital | -14.4 | -16.26 | -17.69 | -16.6 | -22.22 | |
Average receivables | 8.72B | 8.77B | 8.69B | 8.95B | 9.57B | |
Average payables | 4.2B | 4B | 3.8B | 3.98B | 4.19B | |
Average inventory | 2.04B | 2.08B | 2.07B | 2.04B | 2.03B | |
Days sales outstanding | 51.64 | 49.97 | 49.44 | 50.97 | 51.84 | |
Days payables outstanding | 157.06 | 140 | 138.85 | 154.12 | 147.43 | |
Days of inventory on hand | 76.62 | 77.45 | 74.46 | 75.59 | 70.39 | |
Receivables turnover | 1.74 | 1.8 | 1.82 | 1.77 | 1.74 | |
Payables turnover | 0.57 | 0.64 | 0.65 | 0.58 | 0.61 | |
Inventory turnover | 1.17 | 1.16 | 1.21 | 1.19 | 1.28 | |
ROE | -0.75 | -0.55 | -0.52 | -0.44 | -0.91 | |
Capex per share | -4.77 | -4.32 | -4.52 | -4.23 | -4.36 |
HCA Frequently Asked Questions
What is HCA Healthcare, Inc. stock symbol ?
HCA Healthcare, Inc. is a US stock , located in Nashville of Tn and trading under the symbol HCA
Is HCA Healthcare, Inc. buy or a sell ?
47 stock analysts have 47 predictions with a medium analyst target price of $258.87. The lowest prediction is $199 and the highest is $315
What is HCA stock prediction ?
What is HCA Healthcare, Inc. stock quote today ?
HCA Healthcare, Inc. stock price is $333.53 today.
Is HCA Healthcare, Inc. stock public?
Yes, HCA Healthcare, Inc. is a publicly traded company.